Sign in
FI

FIDUS INVESTMENT Corp (FDUS)·Q1 2025 Earnings Summary

Executive Summary

  • Q1 2025 total investment income was $36.5M (+5.3% YoY) and net investment income (NII) was $18.2M ($0.53/share); adjusted NII was $18.5M ($0.54/share). NAV increased to $19.39 per share; the Board declared Q2 dividends totaling $0.54/share (base $0.43 + supplemental $0.11).
  • Results were modestly ahead of consensus: EPS estimate $0.538* vs actual $0.54 (in line to slight beat), and revenue estimate $35.7M* vs actual $36.5M (+$0.8M, ~+2.2%). [Values retrieved from S&P Global]
  • Portfolio originations were $115.6M (94% first-lien) across seven new companies; repayments/realizations were $57.3M, with $11.5M net realized gains contributing to NAV.
  • Liquidity strengthened with March issuance of $100M 6.75% notes due 2030; ending cash was $67.5M and revolver availability $140M. Management plans to redeem $25M of 2026 notes in May and is open to additional debt issuance in 2H25.
  • Credit quality remains healthy: nonaccruals were under 1% of fair value (3.9% of cost) and direct tariff exposure is just over 5% of the portfolio; management sees a volatile but potentially attractive investment environment in lower middle market private credit.

What Went Well and What Went Wrong

What Went Well

  • Realizations and equity monetization: two equity exits (including Medsurant Holdings) drove $11.5M net realized gains, supporting NAV growth. “We also monetized two equity investments for a net realized gain of $11.5 million, or $0.33 per share, which contributed to the increase in NAV.”
  • High-quality originations with first-lien focus: $111.6M debt originations, ~94% first lien; co-invested equity in six of seven new names, consistent with balanced income/capital gains strategy.
  • Dividend sustainability and spillover: declared Q2 dividends of $0.54/share; estimated spillover income remained robust at $47.4M ($1.36/share).

What Went Wrong

  • Yield pressure and fee income softness: weighted average effective yield on debt edged down to 13.2% (from 13.3% in Q4), and fee income declined QoQ amid lower prepayment/amendment activity.
  • Higher interest and financing costs: weighted average debt cost rose to 4.8% with incremental debt; interest expense increased with higher balances and rates.
  • Isolated credit challenges: management acknowledged distressed marks at Quest Software (over-levered, LME risk) and Quantum IR on nonaccrual with elevated risk; continued valuation write-downs in select names.

Financial Results

Quarterly Trends (oldest → newest)

MetricQ3 2024Q4 2024Q1 2025
Total Investment Income ($USD Millions)$38.382 $37.457 $36.496
Net Investment Income ($USD Millions)$21.411 $18.648 $18.222
NII per Share ($)$0.64 $0.55 $0.53
Adjusted NII ($USD Millions)$20.424 $18.437 $18.509
Adjusted NII per Share ($)$0.61 $0.54 $0.54
Net Increase in Net Assets ($USD Millions)$16.477 $17.593 $19.658
Net Increase in Net Assets per Share ($)$0.49 $0.52 $0.58

YoY Comparison (Q1 2024 → Q1 2025)

MetricQ1 2024Q1 2025
Total Investment Income ($USD Millions)$34.651 $36.496
Net Investment Income ($USD Millions)$17.627 $18.222
NII per Share ($)$0.57 $0.53
Adjusted NII ($USD Millions)$18.126 $18.509
Adjusted NII per Share ($)$0.59 $0.54
Net Increase in Net Assets ($USD Millions)$20.123 $19.658
Net Increase in Net Assets per Share ($)$0.65 $0.58

Estimates vs Actual (Q1 2025)

MetricConsensus EstimateActualBeat/(Miss)
EPS ($)$0.538*$0.54 +$0.002
Revenue ($USD Millions)$35.696*$36.496 +$0.800

Values retrieved from S&P Global.

Portfolio and KPI Snapshot (oldest → newest)

KPIQ3 2024Q4 2024Q1 2025
Total Portfolio Fair Value ($USD Millions)$1,090.7 $1,090.5 $1,154.4
Portfolio FV as % of Cost (%)101.5% 101.4% 100.5%
Weighted Avg Yield on Debt (%)13.8% 13.3% 13.2%
Variable Rate Debt ($USD Millions)$702.0 $704.0 $740.3
Variable Rate Debt (% of Debt FV)73.2% 74.5% 72.8%
Originations ($USD Millions)$65.9 $120.3 $115.6
Repayments/Realizations ($USD Millions)$50.8 $122.8 $57.3
Net Realized Gains ($USD Millions)$(0.4) $(0.5) $11.5
NAV per Share ($)$19.42 $19.33 $19.39
Equity Portfolio FV ($USD Millions)——$137.8
First-Lien Share of New Debt (%)——~94%

Liquidity & Leverage (point-in-time)

MetricQ3 2024Q4 2024Q1 2025
Cash & Cash Equivalents ($USD Millions)$54.4 $57.2 $67.5
Revolver Availability ($USD Millions)$100.0 $95.0 $140.0
SBA Debentures Outstanding ($USD Millions)$175.0 $175.0 $182.0
Notes Outstanding ($USD Millions)$250.0 $250.0 $350.0
Weighted Avg Interest Rate on Debt (%)4.6% 4.6% 4.8%
Net Debt-to-Equity (x)——0.7x
Statutory Leverage excl. SBA (x)——0.5x
New Notes Issued——$100M 6.75% due 2030

Guidance Changes

MetricPeriodPrevious GuidanceCurrent GuidanceChange
Quarterly Dividend (Base + Supplemental)Q1 2025Declared $0.43 + $0.11 on Feb 18, 2025 Paid $0.43 + $0.11 on Mar 27, 2025 Maintained
Quarterly Dividend (Base + Supplemental)Q2 2025N/ADeclared $0.43 + $0.11; payable Jun 25, 2025 Maintained
Debt Capital Plan2H 2025N/AManagement would “like to see us raise additional debt capital in the second half of this year” New indication
Notes RedemptionMay 2025N/APlan to redeem $25M of notes due Jan 2026 later in May New action

No formal revenue/margin/tax guidance provided; management commentary emphasized continued disciplined originations and balanced income/capital gains strategy.

Earnings Call Themes & Trends

TopicPrevious Mentions (Q3 2024 and Q4 2024)Current Period (Q1 2025)Trend
M&A & deal environmentReasonable activity; originations exceeded repayments in FY24 (+13.8% AUM); focus on high-quality credits Lower middle market activity lackluster; pipeline supports continued originations; potential for attractive spreads in more complex situations Softer volumes; selective opportunities
Tariffs/macroMacro caution; portfolio constructed defensively Direct tariff exposure just over 5%; management views plans at high/medium risk names as prudent; overall manageable Elevated uncertainty but contained exposure
Yields & feesYields down vs prior year; fees mixed Weighted average yield 13.2% (down from 13.3% in Q4); fee income down QoQ Mild compression
Credit qualityPortfolio healthy overall; nonaccrual not highlighted Nonaccrual under 1% FV (3.9% cost); quest credit challenges acknowledged; Quantum IR on nonaccrual Stable but watchlist items
Leverage & fundingWeighted avg debt cost 4.6%; cash $57M; capacity $95M Issued $100M notes at 6.75%; debt cost 4.8%; cash $67.5M; capacity $140M; considering additional issuance in 2H25 Higher rate funding; greater flexibility
Prepayment riskNot emphasized Ongoing prepayment/refinancing risk among top performers; typical quarter mix Persistent

Management Commentary

  • “We continued to build our portfolio of debt and equity investments in a methodical and disciplined manner during the first quarter by investing in high quality businesses with defensive characteristics and resilient business models that generate high levels of cash flow to service debt and support growth.” (Edward Ross, CEO)
  • “As we look forward, we believe we are well positioned from a capitalization and liquidity position… And should economic conditions deteriorate, our debt portfolio is well positioned to weather a storm.” (Prepared remarks)
  • “Our philosophy of managing the business cautiously and deliberately in the long-term interest of our shareholders keeps us active and focused on generating attractive risk-adjusted returns while preserving capital.”
  • “We recognize tariff uncertainty… Fidus’ direct exposure to tariffs is quite limited, just over 5% of our portfolio… plans being put in place are prudent… situations are very manageable.”

Q&A Highlights

  • Tariff exposure and mitigation: Direct exposure just over 5%; management believes plans at higher risk names are prudent and the overall situation manageable despite market “chaos.”
  • M&A market and spreads: Uncertainty is the primary headwind; spreads stable for A+ credits; potential widening in more complex cases; lower middle market activity continues albeit at reduced levels.
  • Funding strategy and maturities: $100M notes issuance creates near-/medium-term flexibility; potential additional debt raise in 2H25; optionality to address $100M due Jan 2026.
  • Prepayment/refinancing dynamics: Ongoing prepayment risk among high performers; expected mix of M&A exits and refinancings typical for the portfolio.
  • Specific credits: Quest Software marked at distressed levels; over-levered with higher rates; LME risk reflected in valuations; Quantum IR on nonaccrual with company-specific negative events.

Estimates Context

  • EPS: Q1 2025 EPS was $0.54 vs consensus $0.538* (slight beat). Revenue: $36.5M vs consensus $35.7M* (beat of ~$0.8M).
  • Implications: Modest revenue outperformance and in-line EPS suggest limited near-term estimate revisions; fee and yield headwinds could cap upward EPS revisions absent stronger realization/prepayment fees.

Values retrieved from S&P Global.

Key Takeaways for Investors

  • Dividend continuity with robust spillover: Q2 dividend maintained at $0.54/share, supported by $47.4M spillover income.
  • Balanced income and capital gains: $11.5M realized gains and first-lien-heavy originations underpin both recurring income and NAV accretion potential.
  • Funding flexibility: $100M 2030 notes and higher revolver capacity enhance liquidity; management open to further issuance in 2H25; near-term note redemption reduces maturity overhang.
  • Credit monitoring: Nonaccruals remain low (<1% FV) but select names (Quest, Quantum IR) warrant attention; valuation marks reflect risks.
  • Yield/fee sensitivity: Slight yield compression and lower fee income QoQ indicate sensitivity to prepayments and origination mix; watch for fee-rich activity to support EPS.
  • Macro/tariffs: Direct tariff exposure is limited (~5%), but broader uncertainty can slow M&A; management sees potential for attractive opportunities in higher-volatility markets.
  • Trading setup: In-line/slight beat quarter with dividend reaffirmation and realized gains; catalysts include additional debt raise, note redemption, and potential equity monetizations; watch estimate revisions tied to fee/prepayment dynamics.